期刊文献+

不同温度、时间制备新鲜冰冻血浆中各种凝血因子含量研究 被引量:16

An Effect of Temperature and Time on Clotting Factor Preparations from Fresh Frozen Plasma
在线阅读 下载PDF
导出
摘要 目的对不同温度、时间制备的新鲜血浆进行检测,观察FⅤ、FⅦ、FⅧ、FⅨ、FⅩ凝血因子活性的变化情况,以发挥对临床血浆输注或制备冷沉淀选择原料血浆的指导作用。方法在2℃~6℃、15℃左右和室温各制备20份血浆,每一试管留取5ml,同一温度、不同时间来源于同一份血浆,分别于6h、8h、10h、14h、18h速冻标本,并在72h内将速冻成固体的血浆与37℃水温解冻后立即运用血凝法检测各凝血因子活性。结果 2℃~6℃环境中保存的血浆在6h、8h、10h、14h、18h内Fib、FⅦ、FⅨ、FⅩ因子活性的降低不是太明显,但均在正常范围内,而FⅤ、FⅧ因子活性在6~10h也在正常范围,但在14~18h时出现低于正常值的现象。15℃左右和室温保存的血液在6~10h制备FFP中的Fib、FⅦ、FⅨ、FⅩ因子活性下降速度不明显,FⅤ、FⅧ因子随着温度升高和保存时间的延长活性下降速度明显,8~10h与6h相比,所有凝血因子水平的降低都有统计学意义。结论采集的血液保存在2℃~6℃环境中制备的新鲜冰冻血浆中凝血因子活性优于15℃、室温情况下保存血液制备的FFP,建议血站成分科制备冷沉淀原料血浆时,最好用2℃~6℃冷藏环境6~10h内和15℃、室温环境下8h内制备的新鲜冰冻血浆作为制备冷沉淀的原料血浆。 Objective Five blood coagulation factors of Fib,FⅤ,FⅦ,FⅧ,FⅨ and FⅩ were tested in fresh plasma prepared at different temperatures and times in order to guide the preparation of plasma and cryoprecipitation for clinical transfusion.Methods Twenty samples of plasma were prepared under 2℃~6℃,15℃ and room temperature,respectively,with 5ml in each tube.All test samples were frozen for 6h,8h,10 h,14h,and 18 h,and thawed at 37℃ water bath.The activity of coagulation factors of the plasma was tested with clotting method in 72 h.Results No activity of the 5factors was reduced preserved under 2℃~6℃for 6h,8h,10 h,14h,and 18 h,respectively.Factors FⅤ and FⅧ,however,partially lost the activity under 14h^18h.No remarkable reduction of activity of Fib,FⅦ,FⅨ,and FⅩ was found preserved at 15℃ or room temperature for 6h^10h,but FⅤ and FⅧ gradually lost their functions with increase of temperature and the preservation duration.Conclusion Storage of fresh frozen plasma at 2℃~6℃ might keep the activity of coagulation factors compared with stored at 15℃ or at room temperature.Plasma for cryoprecipitation should be prepared at 2℃~6℃ within 6~10h,or at 15℃ or room temperature within 8h.
出处 《临床输血与检验》 CAS 2015年第2期128-131,共4页 Journal of Clinical Transfusion and Laboratory Medicine
关键词 不同温度 不同时间 冰冻血浆 凝血因子 Plasma preparation Conditioning Clotting factors
作者简介 王晓峰(1970-),男,河南濮阳人,主治医师,学士,主要从事献血服务管理、献血招募工作,(Tel)18939366658(E—mail)396451292@qq.com
  • 相关文献

参考文献4

二级参考文献19

  • 1黄文杰,范恩勇,孙海英,纪燕,郭铭华,王爱华,周健.亚甲蓝光化学法病毒灭活血浆对凝血因子的影响[J].实用医学杂志,2006,22(18):2193-2194. 被引量:21
  • 2倪小菊,郑岚,钱开诚.亚甲蓝光化学法灭活病毒的分子生物学机制[J].临床输血与检验,2007,9(1):85-88. 被引量:21
  • 3Richard K, Spence MD. FACS. Clinical use of plasma and plasma fractions. Best Practice & Research Clinical Haematology,200fi, 19 ( 1 ) :83-96.
  • 4中国人民共和国卫生部,中国国家标准化管理委员会.GB18469-2012全血及成分血质量要求.北京:中国标准出版社,2012.
  • 5Scott E, Puac K , Heraly J, et al. Wvaluation and comparison of co- agulation factor activity in fresh-frozen plasma and 24-hour plasma at thaw and after 120 hours of i to 6℃ storage. Transfusion ,2009, 49(8) :1584-1591.
  • 6魏延民,王憬惺.新鲜冰冻血浆的临床应用及其安全性研究进展[J].中国输血杂志,2007,20(5):432-434. 被引量:20
  • 7Mohr H, Kniiver-Hopf J,Gravemann U, et al. West Nile virus in plasma is highly sensitive to methylene blue-light treatment [J]. Transfusion, 2004, 44 (6) .. 886-890.
  • 8McCullough J. Pathogen inactivation: a new paradigm for preventing transfusion-transmitted infections[J]. Am J Clin Patho1,2007,128(6) :945-955.
  • 9Williamson LM,Cardigan R, Prowse CV. Methylene blue-treated fresh-frozen plasma: what is its contribu- tion to blood safety[J]. Transfusion, 2003,43 (9): 1322-1329.
  • 10Solheim BG. Pathogen reduction of blood components I-J]. Transfus Apher Sei,2008,39(1):75-82.

共引文献40

同被引文献126

引证文献16

二级引证文献69

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部